Literature DB >> 11591512

Small molecule somatostatin receptor subtype-2 antagonists.

B A Hay1, B M Cole, F M DiCapua, G W Kirk, M C Murray, R A Nardone, D J Pelletier, A P Ricketts, A S Robertson, T W Siegel.   

Abstract

The first potent small molecule sst2 antagonists are reported. Altering known sst2 agonist molecules yielded compounds with high sst2 binding affinity and full antagonist activity. Compound 7a, for example, displaced somatostatin binding to the sst2 receptor with an IC(50)=2.9 nM and antagonized somatostatin action with an IC(50)=29nM.

Mesh:

Substances:

Year:  2001        PMID: 11591512     DOI: 10.1016/s0960-894x(01)00568-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs.

Authors:  Davide Cervia; Dominique Fehlmann; Daniel Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

2.  Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.

Authors:  Caroline Nunn; Davide Cervia; Daniel Langenegger; Laurent Tenaillon; Rochdi Bouhelal; Daniel Hoyer
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

3.  Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.

Authors:  Davide Cervia; Caroline Nunn; Dominique Fehlmann; Daniel Langenegger; Edi Schuepbach; Daniel Hoyer
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.